Back
ProShares Ultra Nasdaq Biotechnology Vs. Repligen Industry Stock Comparison
Sell
25
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
53.60
Seasonality Move:
14.68%
Sell
30
RGEN
Repligen
Last Price:
124.90
Seasonality Move:
7.3%
Sell
25
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $53.66. The Score for BIB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $53.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.98 | Sell |
Relative Strength Index (14 RSI): | 27.68 | Sell |
Chaikin Money Flow: | -26794 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.22 - 65.54) | Sell |
Bollinger Bands (100): | (60.9 - 66.74) | Sell |
RGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 36.22 | Sell |
Chaikin Money Flow: | -1285419 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.94 - 146.38) | Sell |
Bollinger Bands (100): | (130 - 153.64) | Sell |
BIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.58 | Sell |
20-day SMA: | 62.39 | Sell |
50-day SMA: | 63.48 | Sell |
200-day SMA: | 59.98 | Sell |
8-day EMA: | 60.65 | Sell |
20-day EMA: | 62.16 | Sell |
50-day EMA: | 62.98 | Sell |
200-day EMA: | 60.42 | Sell |
RGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 142.02 | Sell |
20-day SMA: | 140.23 | Sell |
50-day SMA: | 141.19 | Sell |
200-day SMA: | 157.58 | Sell |
8-day EMA: | 139.7 | Sell |
20-day EMA: | 140.54 | Sell |
50-day EMA: | 141.71 | Sell |
200-day EMA: | 151.3 | Sell |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Repligen Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |